The Effect of Progestogen Add-back Therapy on Skeletal Status During GnRH Agonist Therapy for Endometriosis.

Hyoung Moo Park, Woo Seok Lee, Min Seok Song, Min Hee Hur
In: Obstetrics & Gynecology Science · 2003 · vol. 46(2) , pp. 288–295 · W2377019121
article OA: closed CC0 Metadata only
View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-08-27 ⓘ

This study evaluated whether progestogen add-back therapy prevents bone loss induced by GnRH agonist treatment in 30 patients with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

목적 : 자궁내막증의 내과적 치료시 사용되는 GnRH agonist는 골소실의 촉진을 유발하므로 GnRH agonist의 투여시 progestogen add-back 치료를 시행하여 골다공증의 예방의 가능성을 조사하여 보고자 하였다. 연구 방법 : 1996년 4월부터 2001년 6월 사이에 자궁내막증으로 진단받은 환자 30명을 대상으로 GnRH agonist 치료를 한 군과 GnRH agonist/progestogen add-back 치료를 한 군으로

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK